These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27481905)

  • 1. Ability of a Urine Assay of Type II Collagen Cleavage by Collagenases to Detect Early Onset and Progression of Articular Cartilage Degeneration: Results from a Population-based Cohort Study.
    Poole AR; Ha N; Bourdon S; Sayre EC; Guermazi A; Cibere J
    J Rheumatol; 2016 Oct; 43(10):1864-1870. PubMed ID: 27481905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
    Cibere J; Thorne A; Kopec JA; Singer J; Canvin J; Robinson DB; Pope J; Hong P; Grant E; Lobanok T; Ionescu M; Poole AR; Esdaile JM
    J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of synovial fluid and urinary C2C-HUSA levels with surgical outcomes post-total knee arthroplasty.
    Sandhu A; Espin-Garcia O; Rockel JS; Lively S; Perry K; Mohamed NN; Raja Rampersaud Y; Perruccio AV; Robin Poole A; Gandhi R; Kapoor M
    Osteoarthritis Cartilage; 2024 Jan; 32(1):98-107. PubMed ID: 37805006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study.
    Cibere J; Zhang H; Garnero P; Poole AR; Lobanok T; Saxne T; Kraus VB; Way A; Thorne A; Wong H; Singer J; Kopec J; Guermazi A; Peterfy C; Nicolaou S; Munk PL; Esdaile JM
    Arthritis Rheum; 2009 May; 60(5):1372-80. PubMed ID: 19404937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.
    Dam EB; Byrjalsen I; Karsdal MA; Qvist P; Christiansen C
    Osteoarthritis Cartilage; 2009 Mar; 17(3):384-9. PubMed ID: 18768336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between urinary C-telopeptide fragments of type II collagen and knee structure in middle-aged women without clinical knee disease.
    Wang B; Pramono HK; Cicuttini FM; Hanna F; Davis SR; Bell RJ; Wang Y
    Osteoarthritis Cartilage; 2014 Aug; 22(8):1136-41. PubMed ID: 24971869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes.
    Raynauld JP; Martel-Pelletier J; Berthiaume MJ; Beaudoin G; Choquette D; Haraoui B; Tannenbaum H; Meyer JM; Beary JF; Cline GA; Pelletier JP
    Arthritis Res Ther; 2006; 8(1):R21. PubMed ID: 16507119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.
    Verstappen SM; Poole AR; Ionescu M; King LE; Abrahamowicz M; Hofman DM; Bijlsma JW; Lafeber FP;
    Arthritis Res Ther; 2006; 8(1):R31. PubMed ID: 16507130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure.
    Berry PA; Maciewicz RA; Wluka AE; Downey-Jones MD; Forbes A; Hellawell CJ; Cicuttini FM
    Ann Rheum Dis; 2010 Oct; 69(10):1816-22. PubMed ID: 20551154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.
    Bruyere O; Collette J; Kothari M; Zaim S; White D; Genant H; Peterfy C; Burlet N; Ethgen D; Montague T; Dabrowski C; Reginster JY
    Ann Rheum Dis; 2006 Aug; 65(8):1050-4. PubMed ID: 16396978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of cartilage biomarkers in progressive knee osteoarthritis: cross-sectional and 6-year follow-up study in middle-aged subjects.
    Kumm J; Tamm A; Lintrop M; Tamm A
    Rheumatol Int; 2013 Apr; 33(4):903-11. PubMed ID: 22821260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.
    Kong SY; Stabler TV; Criscione LG; Elliott AL; Jordan JM; Kraus VB
    Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis.
    Conrozier T; Poole AR; Ferrand F; Mathieu P; Vincent F; Piperno M; Verret C; Ionescu M; Vignon E
    Clin Exp Rheumatol; 2008; 26(3):430-5. PubMed ID: 18578964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression.
    Deberg MA; Labasse AH; Collette J; Seidel L; Reginster JY; Henrotin YE
    Osteoarthritis Cartilage; 2005 Dec; 13(12):1059-65. PubMed ID: 16154771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased urinary type II collagen C-telopeptide levels in Tunisian patients with knee osteoarthritis.
    Kalai E; Bahlous A; Charni N; Bouzid K; Sahli H; Chelly M; Meddeb M; Zouari B; Abdelmoula J; Sellami S
    Clin Lab; 2012; 58(3-4):209-15. PubMed ID: 22582493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis.
    Cahue S; Sharma L; Dunlop D; Ionescu M; Song J; Lobanok T; King L; Poole AR
    Osteoarthritis Cartilage; 2007 Jul; 15(7):819-23. PubMed ID: 17344068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
    Maksymowych WP; Poole AR; Hiebert L; Webb A; Ionescu M; Lobanok T; King L; Davis JC
    J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of cartilage damage and osteoarthritis progression on magnetic resonance imaging in a population-based cohort with knee pain.
    Cibere J; Sayre EC; Guermazi A; Nicolaou S; Kopec JA; Esdaile JM; Thorne A; Singer J; Wong H
    Osteoarthritis Cartilage; 2011 Jun; 19(6):683-8. PubMed ID: 21329760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.